Related Experiment Videos
Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy
S M Weiss1, P M Roblin, C A Gaydos
1Department of Medicine, State University of New York Health Sciences Center at Brooklyn, USA.
Abstract:
To further investigate a proposed relationship between Chlamydia pneumoniae and coronary heart disease, coronary atheromas were collected from patients undergoing percutaneous atherectomy. Fifty-eight atheroma specimens were examined by culture and polymerase chain reaction (PCR) and 22 by electron microscopy. All were negative for C. pneumoniae, except a single specimen that was PCR-positive. These results differ from studies in other populations, in which this organism was identified by nonculture methods within coronary atheromas obtained at autopsy. Anti-C. pneumoniae antibody titers from 65 of the patients were compared with those of 28 asymptomatic controls. IgG titers were higher in controls than in patients. There is no evidence that C. pneumoniae exists within atheromas in this study population, nor does seroprevalence correlate with the presence of coronary disease in these patients.
Insights
This study found no evidence of Chlamydia pneumoniae in coronary atheromas from patients with coronary heart disease. Seroprevalence of anti-C. pneumoniae antibodies did not correlate with disease presence in this population.
Area of Science:
- Cardiovascular Science
- Infectious Disease Research
- Microbiology
Background:
- A proposed link exists between Chlamydia pneumoniae infection and the development of coronary heart disease.
- Previous studies suggested the presence of C. pneumoniae in atheromatous plaques, but findings varied across populations.
- Investigating the role of infectious agents in atherosclerosis is crucial for understanding disease pathogenesis.
Purpose of the Study:
- To investigate the presence of Chlamydia pneumoniae within coronary atheromas in a specific patient population.
- To determine if serological evidence of C. pneumoniae infection correlates with coronary heart disease in these patients.
- To compare findings with previous studies suggesting an association between C. pneumoniae and atherosclerosis.
Main Methods:
- Coronary atheroma specimens were collected from patients undergoing percutaneous atherectomy.
- Specimens were analyzed using culture, polymerase chain reaction (PCR), and electron microscopy for C. pneumoniae.
- Anti-C. pneumoniae antibody titers (IgG) were measured and compared between patients and asymptomatic controls.
Main Results:
- Chlamydia pneumoniae was not detected in the majority of atheroma specimens by culture, PCR, or electron microscopy.
- A single specimen was PCR-positive for C. pneumoniae; all others were negative.
- IgG antibody titers against C. pneumoniae were higher in asymptomatic controls than in patients with coronary disease.
- No correlation was found between C. pneumoniae seroprevalence and the presence of coronary disease.
Conclusions:
- There is no evidence that Chlamydia pneumoniae resides within coronary atheromas in this study cohort.
- Seroprevalence of C. pneumoniae antibodies does not appear to correlate with coronary heart disease in this population.
- These findings suggest that C. pneumoniae may not play a significant role in atheroma development in this specific demographic, contrasting with some prior research.